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Clinical Pathology inflammatory infiltrate ( Figure 4 ) and foam cells aggregates were present. No atypia, mitosis nor necrosis were documented. The immunohistochemical study showed diffuse positivity for S100 protein ( Figure 5 ), SOX10, and nestin and negativity for smooth muscle actin, desmin, CD34, HMB-45, and Melan ( Figure 6A ). Ki-67 was <1% ( Figure 6B ). These pathologic findings were compatible with the diagnosis of intranodal schwannoma. Lymphocytic thyroiditis was observed in thyroid tissue, with no other lesions detected.
In the view of this very uncommon form of presentation, neurofibromatosis syndromes were considered. In this particular case, bilateral sensorineural hypoacusia was a keypoint to suspect type 2-neurofibromatosis. However, the patient had no pain symptoms that would indicate the existence of schwannomas in other locations and the family history was also negative. 1 Nevertheless, cranial magnetic resonance imaging was performed excluding vestibular or central lesions.
Discussion
Schwannomas-also known as neurilemomas-are benign tumors originating in the peripheral nerve sheath, specifically in the Schwann cells, being closely related to neurofibromas. Malignant transformation is extremely rare in schwannomas. They can originate from any myelinated nerve (i.e. surrounded by Schwann cells), including the cranial nerves (with the exception of the olfactory and optic nerves), as well as autonomic and peripheral nerves. Head and neck, flexor aspects of extremities, posterior mediastinum, and retroperitoneum are common locations, although any site may be involved. About 25%-45% of schwannomas present in the head and neck, with the lateral neck being the most frequent site. 2 Lymphatic involvement is extremely rare and poorly characterized in the literature. 3, 4 Schwannomas affect both genders with an equal incidence and are more frequent between ages of 20 and 50 years. 2 Most schwannomas are solitary; however, in rare instances, they may be multiple or associated to neurofibromatosis and schwannomatosis. On gross examination, schwannomas appear as typically encapsulated masses, located eccentrically to the nerve. The cut surface of the tumor is usually yellow/ white, solid to cystic commonly with myxoid and/or hemorrhagic areas. 2, 4 Microscopically, they are composed of spindle cells with wavy nuclei, and they can present Antoni A and/or Antoni B growth patterns. In the former, there is compact arrangement of the spindle cells which are sometimes arranged in palisades around fibrillary material (Verocay bodies), in a dense fibrous stroma. Antoni B areas are less cellular with spindle cells dispersed in a loose myxoid stroma. 2, [4] [5] [6] Mitosis are rare or absent. Ancilary studies can be helpful confirming this diagnosis, with tumor cells being positive for S100 protein 2,4-7 (family of low-molecular weight proteins present in cells derived from the neural crest) and vimentin (protein found in the cytoskeleton of mesenchymal cells), and showing no evidence of smooth muscle or epithelial differentiation.
Schwannomas should be distinguished from other benign, malignant, or even metastatic spindle-cell tumors. The differential diagnosis for schwannomas arising in a lymph node include, for benign lesions: neurofibroma (nonencapsulated lesions-unlike schwannoma), leiomyoma, palisaded myofibroblastoma and inflammatory pseudotumor of lymph node. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] As for malignant lesions, it must be considered as a malignant peripheral nerve sheath tumor or metastatic lesions such as spindle cell carcinoma, melanoma, or spindlecell sarcoma. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Besides morphology, Schwannomas can be distinguished from leiomyomas and palisaded myofibroblastoma by demonstration of diffuse immunoreactivity for S100 protein, together with the absence of reactivity for muscle markers (desmin and smooth muscle actin). 2, 6 Our case was strongly positive for S100 and negative for smooth muscle actin, thereby ruling out palisaded myofibroblastoma or leiomyoma. In the case of metastatic spindle-cell sarcomas, spindle-cell carcinomas or melanoma, cytological malignant features, and mitotically active spindle cells help distinguishing them from schwannoma. 8 In this case, the tumor was an incidental finding, as similarly described in other case reports. Intranodal schwannomas are rare and only a few reports have been described in the English literature (<15 cases). In most of these reports, schwannomas were located in retroperitoneal or pericolic lymph nodes 3, 5, [7] [8] [9] , thoracic region, 10, 11 and even adjacent to the adrenal gland, 6, 12 with only one case report in the cervical region-Jennifer et al. 4 Therefore, our case is the second cervical intranodal schwannoma described in literature and, to the best of our knowledge, the first to be reported in our country.
Schwannomas may be present either in patients with NF2 or patients with schwannomatosis-opposed to neurofibromas, which may indicate type 1 neurofibromatosis. Particular to NF2 is the presence of vestibular schwannomas. This diagnosis was considered once the patient had bilateral hypoacusia; however, magnetic resonance imaging excluded vestibular and central lesions. Schwanommatosis is part of the spectrum of neurofibromatosis disease (similar to type 2 neurofibromatosis) and is characterized by predisposition to the development of multiple schwannomas, affecting peripheral nerves 
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Clinical Pathology and spinal nerve roots, in the absence of vestibular schwannomas. It can be either inherited or sporadic and is often associated with chronic pain. 1, 13 The patient presented herein had no family history and was asymptomatic. Genetic testing was not conducted.
In conclusion, despite being a rare diagnosis, a schwannoma should be considered in the differential diagnosis of spindlecell tumors arising within a lymph node. It is crucial to correctly identify the residual lymphoid tissue.
